2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
20
Nasopharyngeal Carcinoma
8
Lung Neoplasms
7
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Melanoma
3
Esophageal Squamous Cell Carcinoma
3
Breast Neoplasms
3
Sarcoma
2
Osteosarcoma
2
Nasopharyngeal Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Esophageal Neoplasms
2
Unresectable Non-small Cell Lung Cancer
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Radiation Injuries
1
Quality of Life
1
Pleural Effusion, Malignant
1
Non-squamous Non-small Cell Lung Cancer
1
Neuroblastoma
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Bone Neoplasms
1
Advanced Pancreatic Cancer
1
Interventions
Radiotherapy
38
Radiotherapy, Intensity-Modulated
12
Cisplatin
12
Amifostine
11
Paclitaxel
7
Carboplatin
7
Radiosurgery
6
Etoposide
5
Brachytherapy
5
Surgical Procedures, Operative
4
Low-Level Light Therapy
4
Donepezil
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sargramostim
3
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Neuropsychological Tests
3
Mental Status and Dementia Tests
3
Magnetic Resonance Spectroscopy
3
Heavy Ion Radiotherapy
3
Filgrastim
3
Diet Therapy
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Radiotherapy, Conformal
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Lithium
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radiation Injuries
×
endostar protein
×
Clear all
NCT04274270
2020-03-19
SBRTLCES
Peking University Third Hospital
Phase NA
Unknown
60 enrolled